Previous Next Low-value Care Tests for COVID-19: Has the FDA said yes too many times? Abstract: FDA must focus on ensuring the accuracy of fewer tests that have the best evidence of accuracy so that agencies can evaluate the spread of COVID-19 in each state and each county. Publication: The Hill Date Published: May 6, 2020 Author(s): Robert M. Kaplan and Diana Zuckerman View This Resource